Filing Flows › DataMeds AI (MEDS) › Q2 2026 › vs Q2 2025
DataMeds AI (MEDS) Q2 2026 vs Q2 2025 (year over year)
DataMeds AI's revenue fell $6.0M (-77%) from $7.8M in Q2 2025 to $1.8M in Q2 2026. The biggest changes: Product −$7.5M (-99%); Pharmacy Retail Sales +$1.5M (20×); Third Party Logistics Services −$42K (-25%).
DataMeds AI, Q2 2026: revenue $1.8M (-77% year over year), operating margin -412.7%, net loss $18.4M, operating cash flow −$2.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Pharmacy Retail Sales | $1.6M | $78K | $1.5M | 20× |
| Third Party Logistics Services | $123K | $165K | −$42K | -25% |
| Product | $67K | $7.5M | −$7.5M | -99% |
| Revenue | $1.8M | $7.8M | −$6.0M | -77% |
| Net loss | $18.4M | $6.7M | $11.7M | +175% |
| Costs & expenses | $20.1M | $14.5M | $5.7M | +39% |
| Operating costs | $9.1M | $13.3M | −$4.2M | -31% |
| Interest & other, net | $11.0M | $1.2M | $9.8M | +840% |
| Cost of revenue | $1.6M | $7.3M | −$5.7M | -78% |
| Sales & marketing | $114K | $343K | −$229K | -67% |
| General & admin | $7.1M | $4.9M | $2.2M | +45% |
| Other operating costs | $357K | $803K | −$446K | -56% |
| Operating cash sources | $18.4M | $6.7M | $11.7M | +175% |
| Depreciation & amortization | $357K | $803K | −$446K | -56% |
| Share-based compensation | $1.2M | $935K | $270K | +29% |
| Working capital & other | $13.9M | $2.9M | $11.1M | +387% |
| Cash used in operations | $2.9M | $2.1M | $815K | +39% |
| Net loss absorbed | $18.4M | $6.7M | $11.7M | +175% |
Questions
How much did DataMeds AI's revenue grow year over year in Q2 2026?
DataMeds AI's revenue fell $6.0M (-77%) from $7.8M in Q2 2025 to $1.8M in Q2 2026.
What drove DataMeds AI's revenue change in Q2 2026?
Product −$7.5M (-99%); Pharmacy Retail Sales +$1.5M (20×); Third Party Logistics Services −$42K (-25%).